Healthcare provider profile · identity verified

Andrew Serpe, M.D.

Internal Medicine · AMITYVILLE, NY · NPI 1568545127

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	342	79
Alprazolam	Alprazolam	335	87
Amlodipine Besylate	Amlodipine Besylate	319	76
Rosuvastatin Calcium	Rosuvastatin Calcium	310	89
Metoprolol Succinate	Metoprolol Succinate	285	80
Pantoprazole Sodium	Pantoprazole Sodium	285	95
Lisinopril	Lisinopril	219	52
Atorvastatin Calcium	Atorvastatin Calcium	193	60
Losartan Potassium	Losartan Potassium	188	51
Azithromycin	Azithromycin	178	121
Furosemide	Furosemide	153	53
Metformin Hcl	Metformin Hcl	149	40
Sertraline Hcl	Sertraline Hcl	143	35
Famotidine	Famotidine	142	51
Allopurinol	Allopurinol	130	33
Gabapentin	Gabapentin	124	31
Methylprednisolone	Methylprednisolone	123	91
Prednisone	Prednisone	120	53
Omeprazole	Omeprazole	114	37
Synthroid	Levothyroxine Sodium	114	29
Tramadol Hcl	Tramadol Hcl	112	28
Eliquis	Apixaban	109	19
Celecoxib	Celecoxib	108	27
Lorazepam	Lorazepam	108	15
Hydrochlorothiazide	Hydrochlorothiazide	102	26
Tamsulosin Hcl	Tamsulosin Hcl	102	28
Duloxetine Hcl	Duloxetine Hcl	99	24
Simvastatin	Simvastatin	92	26
Paxlovid	Nirmatrelvir/Ritonavir	89	83
Escitalopram Oxalate	Escitalopram Oxalate	87	26
Ozempic	Semaglutide	86	14
Zolpidem Tartrate	Zolpidem Tartrate	85	15
Clopidogrel	Clopidogrel Bisulfate	79	24
Fluticasone Propionate	Fluticasone Propionate	79	39
Ciprofloxacin Hcl	Ciprofloxacin Hcl	75	54
Myrbetriq	Mirabegron	63	12
Donepezil Hcl	Donepezil Hcl	61	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	58	16
Januvia	Sitagliptin Phosphate	52	12
Potassium Chloride	Potassium Chloride	50	17
Atenolol	Atenolol	49	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	49	suppressed
Oxycodone Hcl	Oxycodone Hcl	49	suppressed
Meloxicam	Meloxicam	48	12
Doxycycline Monohydrate	Doxycycline Monohydrate	46	33
Finasteride	Finasteride	46	14
Montelukast Sodium	Montelukast Sodium	43	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	43	23
Albuterol Sulfate Hfa	Albuterol Sulfate	40	14
Levofloxacin	Levofloxacin	40	28
Clobetasol Propionate	Clobetasol Propionate	39	22
Diazepam	Diazepam	39	14
Pravastatin Sodium	Pravastatin Sodium	39	13
Xarelto	Rivaroxaban	39	suppressed
Ezetimibe	Ezetimibe	38	11
Jardiance	Empagliflozin	38	suppressed
Enalapril Maleate	Enalapril Maleate	36	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	suppressed
Hydrocortisone	Hydrocortisone	34	17
Lidocaine	Lidocaine	34	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	suppressed
Mirtazapine	Mirtazapine	34	suppressed
Ondansetron Odt	Ondansetron	33	16
Warfarin Sodium	Warfarin Sodium	33	suppressed
Amoxicillin	Amoxicillin	31	24
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	17
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Ramipril	Ramipril	28	suppressed
Valsartan	Valsartan	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Carvedilol	Carvedilol	26	suppressed
Glipizide Er	Glipizide	26	suppressed
Prolia	Denosumab	26	13
Alendronate Sodium	Alendronate Sodium	24	suppressed
Amiodarone Hcl	Amiodarone Hcl	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	15
Ketoconazole	Ketoconazole	24	14
Mupirocin	Mupirocin	24	15
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Mounjaro	Tirzepatide	22	suppressed
Risperidone	Risperidone	22	suppressed
Trazodone Hcl	Trazodone Hcl	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	21	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	20	12
Torsemide	Torsemide	20	suppressed
Cephalexin	Cephalexin	19	18
Meclizine Hcl	Meclizine Hcl	19	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	11
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Tadalafil	Tadalafil	18	suppressed
Triazolam	Triazolam	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Digoxin	Digoxin	17	suppressed
Naproxen	Naproxen	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Temazepam	Temazepam	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Nystatin	Nystatin	16	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Linzess	Linaclotide	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Ofloxacin	Ofloxacin	14	14
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Cefuroxime	Cefuroxime Axetil	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Paxlovid (Eua)	Nirmatrelvir/Ritonavir	13	13
Ursodiol	Ursodiol	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Tacrolimus	Tacrolimus	12	suppressed
Estradiol	Estradiol	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error